A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion
ANGEL-COAST
1 other identifier
interventional
338
1 country
6
Brief Summary
Compare the effectiveness and safety of contact aspiration (CA) and stent retriever (SR) in acute ischemic stroke patients with basilar artery occlusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2022
CompletedStudy Start
First participant enrolled
November 7, 2022
CompletedFirst Posted
Study publicly available on registry
November 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 27, 2025
February 1, 2025
2.3 years
November 7, 2022
April 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of first pass effect (FPE)
\[The definition of FPE: 1) single pass/use of the device; 2)recanalization of the large vessel occlusion to eTICI 2C/3;3) no use of rescue therapy.\]
24 hours
Secondary Outcomes (15)
Rate of complete reperfusion (eTICI 3) after first-line thrombectomy strategy and at the end of endovascular procedure
24 hours
Rate of near to complete reperfusion (eTICI 2c/3) after first-line thrombectomy strategy and at the end of endovascular procedure
24 hours
Rate of successful reperfusion (eTICI 2b/2c/3) after first-line thrombectomy strategy and at the end of endovascular procedure
24 hours
Rate of Arterial Occlusive Lesion (AOL) recanalization score 3 after first-line thrombectomy strategy and at the end of endovascular procedure
24 hours
Groin puncture time to successful reperfusion time (min)
24 hours
- +10 more secondary outcomes
Study Arms (2)
Contact aspiration first line thrombectomy
EXPERIMENTALPatients will have the mechanical thrombectomy by first-line contact aspiration
Stent retriever first line thrombectomy
ACTIVE COMPARATORPatients will have the mechanical thrombectomy by first-line stent retriever
Interventions
Contant aspiration is an approach that utilizes the advantages of large-bore aspiration catheters that can be easily tracked and introduced into the cerebral circulation to directly remove the thrombus via negative pressure aspiration.
Stent retriever thrombetomy is an approach that utilize sself-expandable stent for thrombectomy. The stent retriever is expanded to capture the thrombus, which immediately may restore blood flow.
Eligibility Criteria
You may qualify if:
- Age≥18 years;
- Acute basilar artery occlusion confirmed by CTA/MRA/DSA;
- Last known well to puncture time≤24 hours;
- pc-ASPECTS score≥6 points;
- Baseline NIHSS score≥10 points;
- Consent to endovascular treatment;
- Informed consent signed.
You may not qualify if:
- Baseline mRS≥3 points;
- Known or suspected severe basilar artery stenosis (\>70%) or chronic occlusion based on history, imaging, or clinical manifestations;
- Refractory hypertension that is difficult to be controlled by drugs (defined as persistent systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg)
- Genetic or acquired hemorrhagic tendency, coagulation factor deficiency or on anticoagulant therapy and International Normalized Ratio (INR) \> 3.0;
- Laboratory tests: baseline blood glucose \<50mg/dl (2.8mmol/L) or \>400mg/dl (22.2mmol/L); Baseline platelet count \<50×109/L;
- Known severe allergy (more severe than skin rash) to contrast agents uncontrolled by medications;
- Females who are pregnant, or those of childbearing, potential with positive urine or serum beta Human Chorionic Gonadotropin test;
- Other circumstances that the investigator considers inappropriate for participation in the trial or that may pose significant risks to patients (such as inability to understand and/or follow the study procedures and/or follow up due to mental disorders, cognitive or emotional disorders).
- CT or MR evidence of acute intracranial hemorrhage (the presence of microbleeds on MRI is allowed);
- Midline shift or herniation, mass effect with effacement of the ventricles;
- Complete cerebellar infarct on CT or MRI with significant mass effect and compression of the 4-th ventricle;
- Complete bilateral thalamic infarction on CT or MRI;
- Inability to endovascular treatment due to Excessive tortuosity, variation, or dissection of the artery;
- Subjects with occlusions in both intracranial vertebral arteries;
- Subjects with occlusions in both anterior and posterior circulation;
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
Beijing Daxing District People's Hospital
Beijing, Beijing Municipality, China
Anyang People's Hospital
Anyang, Henan, China
Zhangzhou Municipal Hospital
Zhangzhou, Henan, China
Baotou Center Hospital
Baotou, Neimenggu, China
Related Publications (1)
Xuan S, Yang M, Sun D, Song L, Gao F, Mo D, Ma N, Pan Y, Liu L, Zhao X, Wang Y, Wang Y, Nogueira R, Miao Z. Contact aspiration versus stent retriever thrombectomy for acute basilar artery occlusion (ANGEL-COAST): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Stroke Vasc Neurol. 2025 Oct 28:svn-2025-004232. doi: 10.1136/svn-2025-004232. Online ahead of print.
PMID: 41151802DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Interventional Neurology
Study Record Dates
First Submitted
November 7, 2022
First Posted
November 14, 2022
Study Start
November 7, 2022
Primary Completion
February 21, 2025
Study Completion
June 30, 2025
Last Updated
April 27, 2025
Record last verified: 2025-02